Structure and Function: Combined Forces in Managing Glaucoma
Agreement of structure and function is pivotal in diagnosis and management of posterior segment disease. The Octopus perimeter provides various built-in modalities that can be invaluable in clinical care. This webinar discusses in detail on how to use the cluster analysis, polar analysis in conjunction with imaging of retinal nerve fiber layer and fundus photography.
At the end of the webinar the participants will:
- Have a clear understanding of structure and function issues in glaucoma.
- Be able to understand the importance of specific protocols in testing visual fields and glaucoma.
- Learn the importance of cluster analysis in management of glaucoma.
- Learn the importance of polar analysis and correlation with OCT-RNFL.
- Be able to better correlate structure and function and use these clinically.
Speaker
Pinakin Davey, OD, PhD, FAAO
Dr. Pinakin Davey is a tenured Professor at Western University of Health Sciences, College of Optometry. He holds Doctor of Optometry (OD) degree from Southern College of Optometry and a Ph.D. from Anglia Ruskin University in Cambridge, England, in the area of glaucoma. His post-doctoral research fellowship at University of Louisville was focused on improving imaging techniques in glaucoma. He has authored over 50 international publications, and has given over 200 conference and invited presentations both nationally and internationally. He is an active researcher and his research work is funded in past and present by the National Institute of Health and industry sponsored FDA trials.
Dr. Pinakin Davey is a tenured Professor at Western University of Health Sciences, College of Optometry. He holds Doctor of Optometry (OD) degree from Southern College of Optometry and a Ph.D. from Anglia Ruskin University in Cambridge, England, in the area of glaucoma. His post-doctoral research fellowship at University of Louisville was focused on improving imaging techniques in glaucoma. He has authored over 50 international publications, and has given over 200 conference and invited presentations both nationally and internationally. He is an active researcher and his research work is funded in past and present by the National Institute of Health and industry sponsored FDA trials.